Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin

Xiaoming Huang(Macau University of Science and Technology), Wenzhe Ma(Macau University of Science and Technology)
Acta Pharmacologica Sinica
February 19, 2021
Cited by 29


Related Papers